Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum creatinine: beyond renal function as a biomarker of adverse outcomes in premature neonates.

Pediatric research·2026
Same author

The CX3CR1/CX3CL1 (fractalkine) pathway in IgA vasculitis nephritis: guilty party or innocent bystander?

Pediatric research·2025
Same author

HIV-1 Nef synergizes with APOL1-G1 to induce nephrocyte cell death in HIV-related kidney diseases.

Disease models & mechanisms·2025
Same author

Progression of HIV-1 CKDs: Viral Load Versus <i>APOL1</i> Risk Alleles.

Kidney international reports·2025
Same author

Notch3 deletion regulates HIV-1 gene expression and systemic inflammation to ameliorate chronic kidney disease.

Disease models & mechanisms·2025
Same author

Piezo, Nephrocyte Function, and Slit Diaphragm Maintenance in Drosophila.

Journal of the American Society of Nephrology : JASN·2024

Related Experiment Video

Updated: May 22, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

HIV-associated nephropathy: a diagnosis in evolution.

Patricio E Ray

    Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
    |May 16, 2012
    PubMed
    Summary

    HIV-1 associated nephropathy (HIVAN) is a kidney disease more common in people of African ancestry. A new study identifies a novel HIVAN variant and shows antiretroviral therapy improves outcomes for all HIV-related kidney diseases.

    Area of Science:

    • Nephrology
    • Virology
    • Genetics

    Background:

    • HIV-1 associated nephropathy (HIVAN) is a severe kidney disease characterized by proteinuria and focal segmental glomerulosclerosis.
    • Individuals of African ancestry exhibit heightened susceptibility to HIVAN, leading to rapid kidney failure.
    • Previous research has focused on limited patient cohorts, particularly those of African ancestry.

    Discussion:

    • The study by Wearne and colleagues presents findings from the largest cohort of HIVAN patients of African ancestry to date.
    • A novel renal histological variant of HIVAN was identified, expanding the spectrum of disease presentation.
    • Antiretroviral therapies demonstrate efficacy in improving clinical outcomes across all HIV-associated renal diseases.

    Key Insights:

    • Identification of a new histological variant of HIVAN in a vulnerable population.

    More Related Videos

    Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
    13:58

    Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

    Published on: September 26, 2011

    Related Experiment Videos

    Last Updated: May 22, 2026

    Peptide-based Identification of Functional Motifs and their Binding Partners
    14:28

    Peptide-based Identification of Functional Motifs and their Binding Partners

    Published on: June 30, 2013

    Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
    13:58

    Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

    Published on: September 26, 2011

  • Confirmation of antiretroviral therapy's benefit for diverse HIV-related kidney conditions.
  • Highlights the importance of genetic and molecular insights into HIVAN pathogenesis.

    • Outlook:

    • Improved recognition of all clinical HIVAN variants is anticipated.
    • Enhanced screening, prevention, and treatment strategies for HIV nephropathies are expected.
    • Further research into the genetic and molecular underpinnings of HIVAN will refine therapeutic approaches.